Article
Amgen gets FTC's go-ahead for $27.8 billion Horizon deal
Rating:
0.0
Views:
38
Likes:
1
Library:
1
The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics , while preventing the drugmaker from using anticompetitive tactics to extend the market dominance of two Horizon drugs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value